Analystreport

Insys Therapeutics Inc (NASDAQ: INSY) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

INSYS THERAPEUTICS  (INSY) 
Last insys therapeutics earnings: 11/5 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.insysrx.com